The Apple Watch Series 9 can detect atrial fibrillation — a dangerous irregular heartbeat — and alert its wearer before they experience any symptoms. The Fitbit can identify sleep patterns associated with metabolic syndrome risk. A new generation of continuous glucose monitors allows people with diabetes to track their blood sugar in real time without painful finger pricks.
These are genuine medical advances, now available in consumer devices that fit on your wrist. They are also predominantly used by white, college-educated, higher-income Americans — the demographic least likely to develop the chronic diseases these devices are best positioned to detect and prevent.
The Adoption Gap by the Numbers
The Consumer Technology Association reports that wearable health device adoption is 2.5 to 3 times higher among college-educated Americans compared to those without a college degree, and 2 times higher among households earning above $75,000 compared to those below $35,000. Racial disparities are similarly stark.
The communities with the highest rates of obesity, type 2 diabetes, and cardiovascular disease — lower-income communities, Black and Hispanic Americans, rural populations in the Southeast and Appalachia — are the communities with the lowest wearable adoption rates.
"The device that could detect your atrial fibrillation before it kills you is more likely to be worn by someone whose risk of dying from heart disease is lower than the person who actually needs it most. This is not a technology failure. It is a marketing failure — and a research failure."
What My Research Proposes
Paper 7 of my health analytics program examines the behavioral, attitudinal, and structural predictors of wearable health technology adoption across racial, income, and geographic segments in the United States, using a nationally representative sample combined with a conjoint experiment on marketing message framing effects.
The core hypothesis: health outcome expectancy — the perceived health benefit of the device — is the strongest predictor of adoption among lower-income consumers, outweighing cost barriers when health value is clearly communicated. In other words, the marketing message framing matters enormously. And current marketing for wearable health devices is almost entirely framed around fitness performance — not health protection.
The Policy and Market Design Implications
If the adoption gap can be closed through targeted marketing strategy, the public health implications are substantial. Using published data on wearable efficacy for chronic disease prevention, I estimate that closing the adoption gap in the 100 highest-risk U.S. counties could prevent tens of thousands of hospitalizations annually.
This is the kind of research that the White House Cancer Moonshot and the American Heart Association's health equity programs are explicitly calling for — and that marketing analytics researchers are uniquely positioned to produce.
Research Design Note
Paper 7 uses Structural Equation Modeling to identify adoption predictors and a conjoint analysis experiment (n=600 subsample) to identify optimal marketing message framing for different demographic segments. The study concludes with a Medicaid wearable coverage recommendation and a public health impact model estimating lives and hospitalizations preventable through adoption gap closure.
A Personal Note
I wear a fitness tracker. I use its data to make decisions about my sleep, my activity, and my diet. The idea that this capability is effectively unavailable to millions of Americans who need it more than I do is something I find both analytically interesting and morally urgent.
The research I am conducting is my contribution to changing that.